Sandbox:Sahar: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 24: Line 24:
|-
|-
|  T1
|  T1
| I||Growth limited to the [[ovaries]]
| I||Growth limited to one or both [[ovaries]],
|-
|-
| T1a
| T1a
Line 30: Line 30:
|-
|-
| T1b
| T1b
| Ib||Growth limited to both [[ovaries]]; no [[ascites]] present containing [[malignant]] cells. No [[tumor]] on the external [[Surface anatomy|surfaces]]; [[capsules]] intact
| Ib||Growth limited to one or both [[ovaries]]; no [[ascites]] present containing [[malignant]] cells. No [[tumor]] on the external [[Surface anatomy|surfaces]]; [[capsules]] intact
|-
|-
| T1c
| T1c
Line 51: Line 51:
|-
|-
| T3a
| T3a
| IIIa||[[Tumor]] grossly limited to the [[true pelvis]], with negative [[Lymph node|nodes]], but with [[histologically]] confirmed microscopic seeding of [[abdominal]] [[peritoneal]] surfaces, or [[histologic]] proven extension to [[small bowel]] or [[mesentery]]
| IIIa2||[[Tumor]] grossly limited to the [[true pelvis]] with [[histologically]] confirmed microscopic seeding of [[abdominal]] [[peritoneal]] surfaces, or [[histologic]] proven extension to [[small bowel]] or [[mesentery]] with or without positive retroperitoneal lymph nodes
|-
|-
| T3b
| T3b
| IIIb||[[Tumor]] of one or both [[ovaries]] with [[histologically]] confirmed implants, [[peritoneal]] [[metastasis]] of [[abdominal]] [[peritoneal]] surfaces, none exceeding 2 cm in diameter; [[Lymph nodes|nodes]] are negative
| IIIb||[[Tumor]] of one or both [[ovaries]] with [[histologically]] confirmed implants, [[peritoneal]] [[metastasis]] of [[abdominal]] [[peritoneal]] surfaces, none exceeding 2 cm in diameter with or without metastasis to the retroperitoneal lymph nodes
|-
|-
| T3c
| T3c
| IIIc||[[Peritoneal]] [[metastasis]] beyond the pelvis >2 cm in diameter and/or positive regional [[lymph nodes]]
| IIIc||[[Peritoneal]] [[metastasis]] beyond the pelvis >2 cm in diameter with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ)
|-
|-
| AnyT
| AnyT
Line 70: Line 70:
| align="center" style="background:#f0f0f0;" |'''Finding'''
| align="center" style="background:#f0f0f0;" |'''Finding'''
|-
|-
| T1
| N0
| I||Growth limited to the [[ovaries]]
| ||No lymph node involvement
|-
|-
| T1a
| N0(i+)
| Ia||Growth limited to one [[ovary]]; no [[ascites]] present containing [[malignant]] cells. No [[tumor]] on the external [[Surface anatomy|surface]]; [[capsule]] intact
| ||Tumor cells are present in regional lymph node(s), no greater than 0.2 mm
|-
| T1b
| Ib||Growth limited to both [[ovaries]]; no [[ascites]] present containing [[malignant]] cells. No [[tumor]] on the external [[Surface anatomy|surfaces]]; [[capsules]] intact
|-
| T1c
| Ic||[[Tumor]] either stage Ia or Ib, but with the [[tumor]] on [[Surface anatomy|surface]] of one or both [[ovaries]], or with [[capsule]] [[Rupture|ruptured]], or with [[ascites]] present containing [[malignant]] cells, or with positive [[peritoneal]] washings
|-
| T2
| II||Growth involving one or both [[ovaries]] with [[pelvic]] extension
|-
| T2a
| IIa||Extension and/or [[metastases]] to the [[uterus]] and/or tubes
|-
| T2b
| IIb||Extension to other [[pelvic]] tissues
|-
| T2c
| IIc||[[Tumor]] either stage IIa or IIb, but with the [[tumor]] on [[Surface anatomy|surface]] of one or both [[ovaries]], or with [[Capsule|capsule(s)]] ruptured, or with [[ascites]] present containing [[malignant]] cells, or with positive [[peritoneal]] washings
|-
| T3
| III||[[Tumor]] involving one or both [[ovaries]] with [[histologically]] confirmed [[peritoneal]] implants outside the [[pelvis]] and/or positive regional [[lymph nodes]]. [[Superficial]] [[liver]] [[metastases]] equal stage III. The [[tumor]] is limited to the [[true pelvis]], but with [[histologically]] proven [[malignant]] extension to [[small bowel]] or [[omentum]]
|-
|-
| T3a
| N1
| IIIa||[[Tumor]] grossly limited to the [[true pelvis]], with negative [[Lymph node|nodes]], but with [[histologically]] confirmed microscopic seeding of [[abdominal]] [[peritoneal]] surfaces, or [[histologic]] proven extension to [[small bowel]] or [[mesentery]]
| IIIA1||Histologically confirmed retroperitoneal lymph nodes
|-
|-
| T3b
| N1a
| IIIb||[[Tumor]] of one or both [[ovaries]] with [[histologically]] confirmed implants, [[peritoneal]] [[metastasis]] of [[abdominal]] [[peritoneal]] surfaces, none exceeding 2 cm in diameter; [[Lymph nodes|nodes]] are negative
| IIIA1i||Metastasis <and= 10 mm in greatest dimension
|-
|-
| T3c
| N1b
| IIIc||[[Peritoneal]] [[metastasis]] beyond the pelvis >2 cm in diameter and/or positive regional [[lymph nodes]]
| IIIA1ii||Metastasis more than 10 mm in greatest dimension
|-
| AnyT
| IV||Growth involving one or both [[ovaries]] with distant [[Metastasis|metastases]]. If [[pleural effusion]] is present, there must be positive [[cytology]] to allow a case to stage IV. Parenchymal liver metastasis equals stage IV
|-
|-
|+
|+
Line 117: Line 93:
| align="center" style="background:#f0f0f0;" |'''Finding'''
| align="center" style="background:#f0f0f0;" |'''Finding'''
|-
|-
| T1
| M0
| I||Growth limited to the [[ovaries]]
| ||No distant metastasis
|-
|-
| T1a
| M1
| Ia||Growth limited to one [[ovary]]; no [[ascites]] present containing [[malignant]] cells. No [[tumor]] on the external [[Surface anatomy|surface]]; [[capsule]] intact
| IV||Distant metastasis, including positive cytology of pleural effusion; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine
|-
| T1b
| Ib||Growth limited to both [[ovaries]]; no [[ascites]] present containing [[malignant]] cells. No [[tumor]] on the external [[Surface anatomy|surfaces]]; [[capsules]] intact
|-
| T1c
| Ic||[[Tumor]] either stage Ia or Ib, but with the [[tumor]] on [[Surface anatomy|surface]] of one or both [[ovaries]], or with [[capsule]] [[Rupture|ruptured]], or with [[ascites]] present containing [[malignant]] cells, or with positive [[peritoneal]] washings
|-
| T2
| II||Growth involving one or both [[ovaries]] with [[pelvic]] extension
|-
|-
| T2a
| M1a
| IIa||Extension and/or [[metastases]] to the [[uterus]] and/or tubes
| IVa||Pleural effusion with positive cytology
|-
|-
| T2b
| M1b
| IIb||Extension to other [[pelvic]] tissues
| IVb||Liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine
|-
|-
| T2c
| IIc||[[Tumor]] either stage IIa or IIb, but with the [[tumor]] on [[Surface anatomy|surface]] of one or both [[ovaries]], or with [[Capsule|capsule(s)]] ruptured, or with [[ascites]] present containing [[malignant]] cells, or with positive [[peritoneal]] washings
|-
| T3
| III||[[Tumor]] involving one or both [[ovaries]] with [[histologically]] confirmed [[peritoneal]] implants outside the [[pelvis]] and/or positive regional [[lymph nodes]]. [[Superficial]] [[liver]] [[metastases]] equal stage III. The [[tumor]] is limited to the [[true pelvis]], but with [[histologically]] proven [[malignant]] extension to [[small bowel]] or [[omentum]]
|-
| T3a
| IIIa||[[Tumor]] grossly limited to the [[true pelvis]], with negative [[Lymph node|nodes]], but with [[histologically]] confirmed microscopic seeding of [[abdominal]] [[peritoneal]] surfaces, or [[histologic]] proven extension to [[small bowel]] or [[mesentery]]
|-
| T3b
| IIIb||[[Tumor]] of one or both [[ovaries]] with [[histologically]] confirmed implants, [[peritoneal]] [[metastasis]] of [[abdominal]] [[peritoneal]] surfaces, none exceeding 2 cm in diameter; [[Lymph nodes|nodes]] are negative
|-
| T3c
| IIIc||[[Peritoneal]] [[metastasis]] beyond the pelvis >2 cm in diameter and/or positive regional [[lymph nodes]]
|-
| AnyT
| IV||Growth involving one or both [[ovaries]] with distant [[Metastasis|metastases]]. If [[pleural effusion]] is present, there must be positive [[cytology]] to allow a case to stage IV. Parenchymal liver metastasis equals stage IV.
|}
|}

Revision as of 19:05, 11 March 2019


 
 
 
 
 
 
 
Germ cell
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pathogenesis
 
 
 
 
 
 
 
Malignant transformation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mature teratoma
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tumors esxpressing transcription factors of pluripotency
 
Tumors with primitive embryonic ectoderm, mesoderm, and/or endoderm differentiation
 
Tumors with extraembroyonic differentiation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dysgerminoma/Embryonal carcinoma
 
Immature teratoma
 
Yolk sac tumor/Choriocarcinoma
 
Primary tumor
Tumor size FIGO stage Finding
T1 I Growth limited to one or both ovaries,
T1a Ia Growth limited to one ovary; no ascites present containing malignant cells. No tumor on the external surface; capsule intact
T1b Ib Growth limited to one or both ovaries; no ascites present containing malignant cells. No tumor on the external surfaces; capsules intact
T1c Ic Tumor either stage Ia or Ib, but with the tumor on surface of one or both ovaries, or with capsule ruptured, or with ascites present containing malignant cells, or with positive peritoneal washings
T2 II Growth involving one or both ovaries with pelvic extension
T2a IIa Extension and/or metastases to the uterus and/or tubes
T2b IIb Extension to other pelvic tissues
T2c IIc Tumor either stage IIa or IIb, but with the tumor on surface of one or both ovaries, or with capsule(s) ruptured, or with ascites present containing malignant cells, or with positive peritoneal washings
T3 III Tumor involving one or both ovaries with histologically confirmed peritoneal implants outside the pelvis and/or positive regional lymph nodes. Superficial liver metastases equal stage III. The tumor is limited to the true pelvis, but with histologically proven malignant extension to small bowel or omentum
T3a IIIa2 Tumor grossly limited to the true pelvis with histologically confirmed microscopic seeding of abdominal peritoneal surfaces, or histologic proven extension to small bowel or mesentery with or without positive retroperitoneal lymph nodes
T3b IIIb Tumor of one or both ovaries with histologically confirmed implants, peritoneal metastasis of abdominal peritoneal surfaces, none exceeding 2 cm in diameter with or without metastasis to the retroperitoneal lymph nodes
T3c IIIc Peritoneal metastasis beyond the pelvis >2 cm in diameter with or without metastasis to the retroperitoneal lymph nodes (includes extension of tumor to capsule of liver and spleen without parenchymal involvement of either organ)
AnyT IV Growth involving one or both ovaries with distant metastases. If pleural effusion is present, there must be positive cytology to allow a case to stage IV. Parenchymal liver metastasis equals stage IV.
Regional lymph node involvement
Node involvement FIGO stage Finding
N0 No lymph node involvement
N0(i+) Tumor cells are present in regional lymph node(s), no greater than 0.2 mm
N1 IIIA1 Histologically confirmed retroperitoneal lymph nodes
N1a IIIA1i Metastasis <and= 10 mm in greatest dimension
N1b IIIA1ii Metastasis more than 10 mm in greatest dimension
Distant metastasis
Presence of metastasis FIGO stage Finding
M0 No distant metastasis
M1 IV Distant metastasis, including positive cytology of pleural effusion; liver or splenic parenchymal metastasis; metastasis to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); and transmural involvement of intestine
M1a IVa Pleural effusion with positive cytology
M1b IVb Liver or splenic parenchymal metastases; metastases to extra-abdominal organs (including inguinal lymph nodes and lymph nodes outside the abdominal cavity); transmural involvement of intestine